MY-875
Based on 1 publication(s) in Google Scholar
MY-875 is a competitive microtubulin polymerization inhibitor with an IC50 value of 0.92 μM. MY-875 inhibits microtubulin polymerization by targeting colchicine binding sites and activates the Hippo pathway. MY-875 induces apoptosis and has anticancer activity.
For research use only. We do not sell to patients.
- Purity : 99.56%
- Formula: C21H25NO6
- Molecular Weight:387.43
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) MY-875
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.059 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| DU-145 | IC50 |
0.081 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human DU-145 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human DU-145 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| ECa-109 cell line | IC50 |
0.085 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| GES1 | IC50 |
768 nM
Compound: I-33; MY-875
|
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| HCT-116 | IC50 |
0.054 μM
Compound: 4
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36940611] |
| HCT-116 | IC50 |
0.055 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| HGC-27 | IC50 |
0.033 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| Huh-7 | IC50 |
0.06 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| HUVEC | IC50 |
48470 nM
Compound: I-33; MY-875
|
Cytotoxicity against human HUVEC cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human HUVEC cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| KYSE-450 | IC50 |
0.062 μM
Compound: 4
|
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36940611] |
| KYSE-450 | IC50 |
0.067 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| MCF7 | IC50 |
0.067 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| MGC-803 | IC50 |
0.027 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| MGC-803 | IC50 |
0.028 μM
Compound: 4
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36940611] |
| NCI-H520 | IC50 |
0.052 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human NCI-H520 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H520 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| PC-3 | IC50 |
0.055 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| SGC-7901 | IC50 |
0.025 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| SMMC-7721 | IC50 |
0.043 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
| TE-1 | IC50 |
0.094 μM
Compound: I-33; MY-875
|
Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 35834904] |
In Vitro
MY-875 (0-80 μM, 48 h) has significant anti-proliferative activity against cancer cells[1].
MY-875 (1-10 μM) can inhibit microtubule protein polymerization with an IC50 value of 0.92 μM while inhibiting alkylation of β-tubulin and the formation of EBI-β-tubulin adduct bands in a dose-dependent manner[1].
MY-875 (0-45 nM, 48 h) can induce the phosphorylation state of MST (Ste20-like kinases) and LATS (large tumor suppressor kinases), leading to YAP (Yes-associated protein) degradation in a dose-dependent manner[1].
MY-875 (0-45 nM, 24 h) significantly inhibits cell colony-forming ability, arrests cells in the G2/M phase and induces cell apoptosis in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MGC-803, HCT-116, KYSE450, HGC-27, SGC-7901cell lines
-
Concentration:0-80 μM
-
Incubation Time:48 hours
-
Result:Inhibited the proliferation of MGC-803, HCT-116, KYSE450, HGC-27 and SGC-7901 cells with the IC50 values of 0.027, 0.055, 0.067, 0.033 and 0.025 μM, respectively.
Showed strong inhibitory effect on other tumor cell lines with the IC50 values less than 0.1 μM, such as DU145, A549, MCF-7, etc.
-
Cell Line:MGC-803, SGC-7901 cell lines
-
Concentration:0-45 nM
-
Incubation Time:24 hours
-
Result:Increased the percentage of cells in G2/M phase from 19.38% to 76.97% in MGC-803 cells and from 7.04% to 80.89% in SGC-7901 cells, respectively at 45 nM.
-
Cell Line:MGC-803, SGC-7901 cell lines
-
Concentration:0-45 nM
-
Incubation Time:48 hours
-
Result:Induced apoptotic cells from 21.96% to 76.08% in MGC-803 cells and from 9.28% to 63.51% in SGC-7901 cells, respectively at 45 nM.
Reduced expression of anti-apoptotic proteins c-IAP1, Bcl-xL and Mcl-1.
Chemical Information
-
Appearance Solid
-
Molecular Weight 387.43
-
Formula C21H25NO6
-
Color White to off-white
-
SMILES
COC1=CC(N(C(/C=C/C)=O)CC2=CC(O)=C(OC)C=C2)=CC(OC)=C1OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
In Vitro:
DMSO : ≥ 250 mg/mL (645.28 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5811 mL | 12.9056 mL | 25.8111 mL | 64.5278 mL |
| 5 mM | 0.5162 mL | 2.5811 mL | 5.1622 mL | 12.9056 mL | |
| 10 mM | 0.2581 mL | 1.2906 mL | 2.5811 mL | 6.4528 mL | |
| 15 mM | 0.1721 mL | 0.8604 mL | 1.7207 mL | 4.3019 mL | |
| 20 mM | 0.1291 mL | 0.6453 mL | 1.2906 mL | 3.2264 mL | |
| 25 mM | 0.1032 mL | 0.5162 mL | 1.0324 mL | 2.5811 mL | |
| 30 mM | 0.0860 mL | 0.4302 mL | 0.8604 mL | 2.1509 mL | |
| 40 mM | 0.0645 mL | 0.3226 mL | 0.6453 mL | 1.6132 mL | |
| 50 mM | 0.0516 mL | 0.2581 mL | 0.5162 mL | 1.2906 mL | |
| 60 mM | 0.0430 mL | 0.2151 mL | 0.4302 mL | 1.0755 mL | |
| 80 mM | 0.0323 mL | 0.1613 mL | 0.3226 mL | 0.8066 mL | |
| 100 mM | 0.0258 mL | 0.1291 mL | 0.2581 mL | 0.6453 mL |